UNH
聯合健康 UNITEDHEALTH GROUP INC
+2.74 (+0.73%)378.00USD1.4M成交股數339B市值24.3本益比(近四季)0.8股價營收比+0.4%營收年增(近四季)2026-10-13下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 112B+0% | 112B+2% | 113B+12% | 113B+14% | 112B+12% | 110B+16% | 101B+9% | 98.9B+6% | 99.8B | 94.4B | 92.4B | 92.9B |
| 營業成本 | 13.4B | 12.8B | 12.7B | 12.6B | 13.0B | 12.4B | 11.8B | 11.3B | 11.1B | 10.2B | 9.4B | 9.7B |
| 毛利 | 98.7B+0% | 98.9B+2% | 101B+13% | 101B+15% | 98.6B+11% | 97.2B+15% | 89.0B+7% | 87.5B+5% | 88.7B | 84.2B | 82.9B | 83.2B |
| 毛利率 | 88.1% | 88.5% | 88.8% | 88.9% | 88.3% | 88.7% | 88.3% | 88.5% | 88.9% | 89.2% | 89.8% | 89.5% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 14.3B | 15.4B | 17.0B | 15.2B | 13.8B | 13.6B | 13.3B | 13.2B | 14.1B | 13.3B | 13.9B | 13.8B |
| 營業利益 | 8.0B+55% | 9.0B-1% | 380M-96% | 4.3B-45% | 5.2B-35% | 9.1B+19% | 8.7B+2% | 7.9B-2% | 7.9B | 7.7B | 8.5B | 8.1B |
| 營業利益率 | 7.1% | 8.0% | 0.3% | 3.8% | 4.6% | 8.3% | 8.6% | 8.0% | 7.9% | 8.1% | 9.2% | 8.7% |
| 稅後淨利 | 5.5B+61% | 6.3B-0% | 10.0M-100% | 2.3B-44% | 3.4B-342% | 6.3B+15% | 6.1B+4% | 4.2B-23% | −1.4B | 5.5B | 5.8B | 5.5B |
| 淨利率 | 4.9% | 5.6% | 0.0% | 2.1% | 3.1% | 5.7% | 6.0% | 4.3% | -1.4% | 5.8% | 6.3% | 5.9% |
| 稀釋 EPS | 6.04+61% | 6.90+1% | 0.05-99% | 2.59-43% | 3.74-344% | 6.85+17% | 6.51+4% | 4.54-22% | -1.53 | 5.85 | 6.24 | 5.82 |
| 稀釋股數 | 906M | 910M | 911M | 908M | 910M | 918M | 930M | 928M | 922M | 938M | 936M | 940M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 28.6B | 28.0B | 24.4B | 27.2B | 28.6B | 30.7B | 32.4B | 26.3B | 28.4B | 25.4B | 38.9B | 41.8B |
| 應收帳款 | 21.6B | 26.6B | 23.0B | 22.7B | 24.1B | 26.9B | 20.0B | 23.1B | 27.2B | 21.3B | 20.7B | 18.0B |
| 存貨 | – | – | 3.3B | – | – | – | – | – | – | 2.8B | – | – |
| 總資產 | 310B | 313B | 310B | 315B | 309B | 310B | 299B | 286B | 284B | 274B | 282B | 280B |
| 有息負債 | 69.5B | 71.4B | 72.3B | 72.4B | 73.5B | 71.3B | 74.1B | 63.7B | 63.9B | 58.3B | 58.1B | 59.3B |
| 總負債 | 204B | 207B | 208B | 209B | 204B | 205B | 195B | 187B | 187B | 175B | 188B | 188B |
| 股東權益 | 105B | 104B | 100B | 102B | 100B | 101B | 99.9B | 94.7B | 92.4B | 94.4B | 89.6B | 87.4B |
| 負債比 | 65.8% | 66.3% | 67.1% | 66.4% | 66.0% | 66.1% | 65.1% | 65.3% | 65.9% | 63.9% | 66.7% | 67.1% |
| 淨現金(現金 − 有息負債) | −40.9B | −43.4B | −48.0B | −45.2B | −44.9B | −40.6B | −41.7B | −37.4B | −35.4B | −32.8B | −19.2B | −17.5B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 8.9B+63% | – | – | – | 5.5B | – | – | 1.1B | – | – | – |
| 資本支出 | – | 763M | – | – | – | 898M | – | – | 743M | – | – | – |
| 自由現金流 | – | 8.1B+79% | – | – | – | 4.6B | – | – | 401M | – | – | – |
| 折舊攤銷 | 1.0B | 1.0B | 1.1B | 1.1B | 1.1B | 1.1B | 1.0B | 1.0B | 997M | 974M | 1.0B | 1.0B |
| 買回庫藏股 | – | 0.00 | – | – | – | 3.0B | – | – | 3.1B | – | – | – |
| 現金股利 | – | 2.0B | – | – | – | 1.9B | – | – | 1.7B | – | – | – |
| 自由現金流率 | – | 7.3% | – | – | – | 4.2% | – | – | 0.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 892B
| Unitedhealthcare | 345B | 38.7% | +15.7% |
|---|---|---|---|
| Total Optum | 271B | 30.4% | +7.0% |
| Optumrx | 155B | 17.4% | +16.1% |
| Optumhealth | 102B | 11.4% | -3.2% |
| Optuminsight | 19.4B | 2.2% | +3.5% |
主要客戶2025 年度 · 444B
| External Customers | 444B | 100.0% | +12.3% |
|---|
產品／服務2025 年度 · 91.4B
| 產品 | 53.4B | 58.4% | +6.3% |
|---|---|---|---|
| 服務 | 38.0B | 41.6% | +5.5% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 448B | +11.8% | 12.1B | 2.7% | 13.23 | 16.1B |
| FY2024 | 400B | +7.7% | 14.4B | 3.6% | 15.51 | 20.7B |
| FY2023 | 372B | +14.6% | 22.4B | 6.0% | 23.86 | 25.7B |
| FY2022 | 324B | +12.7% | 20.1B | 6.2% | 21.18 | 23.4B |
| FY2021 | 288B | +11.8% | 17.3B | 6.0% | 18.08 | 19.9B |
| FY2020 | 257B | +6.2% | 15.4B | 6.0% | 16.03 | 20.1B |
| FY2019 | 242B | +7.0% | 13.8B | 5.7% | 14.33 | 16.4B |
| FY2018 | 226B | – | 12.0B | 5.3% | 12.19 | 13.7B |